
Assisted dying: Thoughts from the front line
These are the doctors and nurse practitioners who sit with patients in their final moments, who navigate complex eligibility criteria, and who carry the emotional weight of helping someone die on their own terms. They are the ones who bring the service to life. And yet, before this research, we knew very little about their experiences.
Why we did this study
The motivation behind this research was simple: to capture what was actually happening in practice. Assisted dying is a new health service in New Zealand, and many practitioners entered it with no roadmap. They were learning as they went, often alone, often unsure, and often deeply moved by the experience.
We wanted to understand their journey, not just to document it, but to help improve the service. If there were challenges, we needed to know. If there were moments of beauty and meaning, we needed to honour those too. Ultimately, this study was about making assisted dying safer and more sustainable for everyone involved, including patients, their families, and providers.
We used a 'memorable case' approach, inviting 22 assisted dying practitioners to reflect on their experiences during the first 12 months of the Act's implementation. These weren't just clinical accounts, they were deeply personal stories that revealed the emotional, ethical, and logistical complexities of assisted dying.
Through thematic analysis, we identified three major themes: 'Knowing', reflecting on practitioners' prior personal and professional experience; 'doing', reflecting on their early assisted dying experiences of delivering this service; and 'being', reflecting on their personal/professional accounts of being an assisted dying provider. These themes helped us understand not just what practitioners did, but how they felt, what they struggled with, and what they learned.
What assisted dying practitioners said
Let's start with the positives because there were many. Practitioners consistently described the experience as a privilege. Despite the anxiety and emotional intensity, particularly during the first couple of service provision, they felt honoured to be part of something so meaningful. For many, the last words they heard from patients were 'Thank you'. That simple phrase carried immense weight. It affirmed that they were helping to end suffering, honour final wishes, help fulfil autonomy and choice, and offer peace.
But there were challenges too, some of which persist today. One major issue is the eligibility criteria, particularly the requirement that a person must be likely to die within six months. This can exclude people who are suffering profoundly but don't meet the strict timeline. Assisted dying practitioners sometimes found themselves in situations where they were challenged to give an exact or accurate prognosis because of the unpredictable nature of many medical conditions.
Another challenge is the regulatory prohibition on raising the topic of assisted dying with patients. Practitioners can't initiate the conversation; it must come from the patient. While this protects against coercion, it also means that many people don't even know the option exists. Some practitioners felt torn: they felt ethically challenged by withholding information about the full range of end-of-life care options, but they couldn't say so. Some others accepted the restriction, fearing that even a well-intentioned suggestion could be misinterpreted.
Assessing suffering was another complex area. There's no standard guideline or measurement tool, and suffering is deeply subjective, which could confuse patients in the evaluation process. Practitioners had to dig deeper, asking about daily activities, joy, and quality of life to understand the full picture. This subjectivity, however, allowed some room to acknowledge other forms of suffering, including psychological, existential, and spiritual suffering. For some practitioners, this subjectivity was seen as a positive point, allowing patients to determine whether and how they were suffering.
Experienced clinicians were often better equipped to do this and acknowledged that assisted dying involves a steep learning curve for junior practitioners.
And then there's the stigma. In smaller communities, some practitioners feared backlash from colleagues, neighbours, and even family. Many kept their involvement quiet, worried about judgment or misunderstanding. For some, this secrecy added another layer of emotional strain to an already demanding role and limited their ability to seek support.
Finally, we must acknowledge the logistical burden. Most assisted dying practitioners were, and still are, doing this work on top of their regular duties, after hours, on weekends, driven by compassion rather than compensation. Their dedication was extraordinary, but it may not be sustainable without better support.
What comes next
This study was just the beginning. It gave us a snapshot of the early days, a time of uncertainty, courage, and profound human connection. Since then, some challenges have been addressed, which is encouraging. But others remain, and we must keep listening, learning, and evolving.
Assisted dying is not just a legal or medical service; it's a deeply human one. If we want it to succeed, we need to support the people who make it possible. That means clearer guidelines, better training, more public awareness, and a culture that values openness over silence.
We are proud of this research and grateful to the practitioners who shared their stories and experiences. Their voices are essential. They remind us that behind every policy is a person and behind every person is a story worth telling.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsroom
11 hours ago
- Newsroom
Assisted dying: Thoughts from the front line
Comment: When the End of Life Choice Act 2019 came into effect in November 2021, it marked a profound shift in how we approach death and dying in New Zealand. As researchers and clinicians our team felt a deep responsibility to understand how this new law was unfolding, not from the top down, but from the ground up. That meant listening to the very people who were making it happen: assisted dying practitioners. These are the doctors and nurse practitioners who sit with patients in their final moments, who navigate complex eligibility criteria, and who carry the emotional weight of helping someone die on their own terms. They are the ones who bring the service to life. And yet, before this research, we knew very little about their experiences. Why we did this study The motivation behind this research was simple: to capture what was actually happening in practice. Assisted dying is a new health service in New Zealand, and many practitioners entered it with no roadmap. They were learning as they went, often alone, often unsure, and often deeply moved by the experience. We wanted to understand their journey, not just to document it, but to help improve the service. If there were challenges, we needed to know. If there were moments of beauty and meaning, we needed to honour those too. Ultimately, this study was about making assisted dying safer and more sustainable for everyone involved, including patients, their families, and providers. We used a 'memorable case' approach, inviting 22 assisted dying practitioners to reflect on their experiences during the first 12 months of the Act's implementation. These weren't just clinical accounts, they were deeply personal stories that revealed the emotional, ethical, and logistical complexities of assisted dying. Through thematic analysis, we identified three major themes: 'Knowing', reflecting on practitioners' prior personal and professional experience; 'doing', reflecting on their early assisted dying experiences of delivering this service; and 'being', reflecting on their personal/professional accounts of being an assisted dying provider. These themes helped us understand not just what practitioners did, but how they felt, what they struggled with, and what they learned. What assisted dying practitioners said Let's start with the positives because there were many. Practitioners consistently described the experience as a privilege. Despite the anxiety and emotional intensity, particularly during the first couple of service provision, they felt honoured to be part of something so meaningful. For many, the last words they heard from patients were 'Thank you'. That simple phrase carried immense weight. It affirmed that they were helping to end suffering, honour final wishes, help fulfil autonomy and choice, and offer peace. But there were challenges too, some of which persist today. One major issue is the eligibility criteria, particularly the requirement that a person must be likely to die within six months. This can exclude people who are suffering profoundly but don't meet the strict timeline. Assisted dying practitioners sometimes found themselves in situations where they were challenged to give an exact or accurate prognosis because of the unpredictable nature of many medical conditions. Another challenge is the regulatory prohibition on raising the topic of assisted dying with patients. Practitioners can't initiate the conversation; it must come from the patient. While this protects against coercion, it also means that many people don't even know the option exists. Some practitioners felt torn: they felt ethically challenged by withholding information about the full range of end-of-life care options, but they couldn't say so. Some others accepted the restriction, fearing that even a well-intentioned suggestion could be misinterpreted. Assessing suffering was another complex area. There's no standard guideline or measurement tool, and suffering is deeply subjective, which could confuse patients in the evaluation process. Practitioners had to dig deeper, asking about daily activities, joy, and quality of life to understand the full picture. This subjectivity, however, allowed some room to acknowledge other forms of suffering, including psychological, existential, and spiritual suffering. For some practitioners, this subjectivity was seen as a positive point, allowing patients to determine whether and how they were suffering. Experienced clinicians were often better equipped to do this and acknowledged that assisted dying involves a steep learning curve for junior practitioners. And then there's the stigma. In smaller communities, some practitioners feared backlash from colleagues, neighbours, and even family. Many kept their involvement quiet, worried about judgment or misunderstanding. For some, this secrecy added another layer of emotional strain to an already demanding role and limited their ability to seek support. Finally, we must acknowledge the logistical burden. Most assisted dying practitioners were, and still are, doing this work on top of their regular duties, after hours, on weekends, driven by compassion rather than compensation. Their dedication was extraordinary, but it may not be sustainable without better support. What comes next This study was just the beginning. It gave us a snapshot of the early days, a time of uncertainty, courage, and profound human connection. Since then, some challenges have been addressed, which is encouraging. But others remain, and we must keep listening, learning, and evolving. Assisted dying is not just a legal or medical service; it's a deeply human one. If we want it to succeed, we need to support the people who make it possible. That means clearer guidelines, better training, more public awareness, and a culture that values openness over silence. We are proud of this research and grateful to the practitioners who shared their stories and experiences. Their voices are essential. They remind us that behind every policy is a person and behind every person is a story worth telling.


Otago Daily Times
27-07-2025
- Otago Daily Times
Business case flawed: Brooking
The release of a "flawed" business case means more information is needed before Labour decides whether it would dump the planned Waikato Medical School, a Dunedin MP says. Last Monday, Health Minister Simeon Brown announced Cabinet had approved $82.85 million in government funding to build the country's third medical school at the University of Waikato — the institution was expected to contribute more than $150m to the project. Dunedin MP Rachel Brooking, of Labour, said she was "very sceptical" about figures used by the government to make its decision. The project's detailed business case was made public on Friday evening, part of a document dump which revealed the cost of producing GPs at the graduate-entry Waikato medical school would be $50 million a year cheaper than at the existing medical schools at Otago and Auckland universities. "The business case has really been written with an outcome in mind and not traversed all of the options, and that's just bad decision-making," Ms Brooking said. "It's bad way to make use of taxpayers' money, and it seems that in general, this all will cost more." She said the "flawed" business case would have consequences for the Otago Medical School: "those are difficult to predict exactly". However, Labour had "no plans at the moment" to dump the medical school, Ms Brooking said. "The issue is that we don't think the business case is credible. "So we'll keep asking questions about that and try and make any assessments on good information when we're in a position to do so." Taieri MP Ingrid Leary said "the so-called business case is really just a public relations document, given the outlandish assumptions and comparators". In a statement last Monday, Mr Brown said the project was an innovative model "that supports our focus on strengthening primary care, making it easier for people to see their doctor — helping Kiwis stay well and out of hospital". Waikato University would begin construction on new teaching facilities later this year. A full cost-benefit analysis was presented to Cabinet before any proposal was finalised, as part of the National-Act New Zealand coalition agreement, he said. Green MP Francisco Hernandez said the government's cost-benefit analysis used to "ram through" the Waikato Medical School made assumptions revealing the "lack of objectivity". Mr Hernandez said the document "falsely assumed" Otago and Auckland universities could not have negotiated a four-year rural graduate programme similar to Waikato University's proposal. "This assumption enables the government to claim that Waikato University will train medical students 'cheaper' because Waikato is assumed to have a four-year programme," he said. The government had also assumed Waikato University was more likely to produce GPs "even though Otago and Auckland could have also done a rural graduate programme". "Fundamentally, these flawed assumptions stem from the government's failure to run a transparent tender process from the start," Mr Hernandez said. "Rather than putting out an open tender to every university in New Zealand, they gave Waikato University a sweetheart deal." He called for the government to "be up front and honest about the actual costs" of the project and release the full agreement with Waikato University with all relevant advice. "The government's failure to rule out further handouts or to release the actual agreement raises questions on whether there were further sweetheart deals negotiated behind closed doors in the agreement that might end up with the taxpayer bailing out Waikato University."


Scoop
21-07-2025
- Scoop
Pharmac Continues To Engage With Consumers
Associate Minister of Health Associate Education Minister David Seymour welcomes the establishment of Pharmac's new consumer working group to help Pharmac help reset how it works with health consumers. "For many New Zealanders, funding for pharmaceuticals is life or death, or the difference between a life of pain and suffering or living freely,' Mr Seymour says. 'My expectation is that Pharmac should have good processes to ensure that people with an illness, their carers and family, can provide input to decision-making processes. This is part of the ACT-National Coalition Agreement. 'Pharmac hosted a Consumer Engagement Workshop in March. Patients and advocates voiced their hopes at resetting the patient – Pharmac relationship. Pharmac published a report on the findings from the workshop. 'The report recommended that the Board invite workshop participants, in association with the wider consumer-patient representative community, to select a working group. The group would work with Pharmac's Board and management to reset the relationship between Pharmac and the consumer/representative community. 'The patient advocacy community selected Dr Malcolm Mulholland to lead the consumer working group. He has worked with consumers to select the other members of the working group. These members represent patients with a wide range of health conditions. They are named at the end of this release.' 'We've waited a long time for this opportunity. The work that Pharmac does is vitally important for the health of patients and their families, and this is why getting Pharmac to work as well as it can, will be the focus of the working group,' Dr Mulholland says. 'The consumer working group met for the first time yesterday to confirm the approach for the reset programme and agree the first set of actions. I look forward to hearing about their progress,' Mr Seymour says. 'I'm pleased to see the Board take the opportunity to continue to prioritise expanding opportunities and access for patients and their families by expanding access to more medicines for more groups. 'The working group reflects our commitment to a more adaptable and patient-centred approach. It follows my letters of expectations, the consumer engagement workshop, last year's Medicines Summit, and the acceptance of Patient Voice Aotearoa's White Paper as actions to achieve this. 'The Government is doing its part. Last year we allocated Pharmac its largest ever budget of $6.294 billion over four years, and a $604 million uplift to give Pharmac the financial support it needs to carry out its functions - negotiating the best deals for medicine for New Zealanders.' The consumer working group members are: Dr Malcolm Mulholland MNZM – Patient Voice Aotearoa Libby Burgess MNZM – Breast Cancer Aotearoa Coalition Tim Edmonds – Leukaemia and Blood Cancer NZ Chris Higgins – Rare Disorders NZ Francesca Holloway – Arthritis NZ Trent Lash – Heartbeats Charitable Trust Gerard Rushton – The Meningitis Foundation Rachel Smalley MNZM – The Medicine Gap Tracy Tierney – Epilepsy NZ Deon York – Haemophilia NZ